Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software
NCT ID: NCT05389072
Last Updated: 2022-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
57 participants
INTERVENTIONAL
2022-06-01
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Success of Habitual Multifocal Wearers When Refit With a New Lens Design
NCT04952701
A Clinical Comparison of Two Soft Contact Lenses (C24-755)
NCT06758076
Assessment of Corneal Biomechanical Properties Using Corvis ST Following LASIK, PRK, and CXL
NCT06818461
North American Comfilcon A Clinical Study
NCT06902584
Multifocal Lens Centration and Its Effect on Visual Performance in a Presbyopic Population
NCT02228109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Lens
control contact lens
control CRT lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
control contact lens
control CRT lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Have had a self-reported visual exam in the last two years
3. Have a contact lens refraction that fits within the available parameters of the study lenses
4. Are able to read (or be read to), understand and sign the assent document if under 18 years old or are able to read, understand and sign the consent document if aged 18 or older (Children 6-years of age will not be asked to sign the assent form as per STERLING IRB.);
5. Are under 18 years old and are accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document;
6. Are willing to comply with the wear schedule (8 hour per night for every night, while sleeping)
7. Are willing to comply with the visit schedule
8. Have a refractive spherical component of their prescription between -0.50 and up to -6.00 diopters (inclusive) AND a refractive cylinder of no more than -1.75 diopters
9. Have a refractive spherical component ≥ cylinder component
10. Have a minimum visual acuity of +0.20 logMAR with each eye, when refracted at the Screening visit
11. Have clear corneas and no active ocular disease
12. Have no medication, medical condition, or ocular conditions that contraindicate contact wear OR are expected to affect lens comfort or vision across the 1-month study duration, in the opinion of the investigator
13. Can be shown to have stable keratometry for at least the previous 1 month, if they have previously worn orthokeratology lenses.
Exclusion Criteria
2. Have a post-treatment predicted flat K value ≤38.00D (e.g. Patient baseline flat keratometry value = 40.00, patient has 2.00D of myopic refractive error. 40.00-2.00= 38.00D)
3. Have a known sensitivity to the diagnostic sodium fluorescein to be used in the study
4. Are pregnant, planning a pregnancy or lactating
5. Have amblyopia
6. Have presbyopia or has dependence on spectacles for near work over the contact lenses
7. Present at screening visit with the presence of clinically significant (grade \>3; Efron scale) anterior segment abnormalities.
8. Present at screening visit with slit lamp findings that would contraindicate orthokeratology contact lens wear such as:
1. Pathological dry eye or associated findings
2. Pterygium, pinguecula, or corneal scars within the visual axis
3. Neovascularization \> 0.75 mm from of the limbus
4. Giant papillary conjunctivitis (GPC) worse than grade 1
5. Anterior uveitis or iritis (past or present)
6. Seborrheic eczema, Seborrheic conjunctivitis
7. History of corneal ulcers or fungal infections
8. Poor personal hygiene
9. Aphakia
6 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
CooperVision International Limited (CVIL)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
4S Eyecare and Optometry
San Diego, California, United States
Carillon Vision Care
Glenview, Illinois, United States
Bellaire Family EyeCare
Bellaire, Texas, United States
University Complutense of Madrid
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ashley Tucker, MD
Role: primary
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEC-P042021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.